Clostridium Diagnostics Market - North America, Europe, EMEA, APAC : US, Canada, China, Germany, UK - Forecast 2023-2027

Published: Feb 2023 Pages: 190 SKU: IRTNTR75006

Clostridium Diagnostics Market Forecast 2023-2027

The Clostridium Diagnostics Market size is estimated to grow by USD 2,148.4 million between 2022 and 2027 accelerating at a CAGR of 13.69%. The prominent factors driving the market growth include the growing prevalence of CDI, the rise in the aging population, and the development of novel therapies.

What will be the size of the Clostridium Diagnostics Market During the Forecast Period?

To learn more about this report, Download Costridium Diagnostics Market Research Report Sample PDF

Market Dynamics

The growing prevalence of CDI is notably driving the market growth, although factors such as scarcity of resources and lack of awareness in developing countries may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Driver

The growing prevalence of CDI is a key factor driving the growth of the global market. A major public health issue on a global scale, CDI has dramatically increased in frequency and severity over the past three decades, which is a major factor driving the growth of the market. Since the turn of the twenty-first century, there has been a significant shift in the epidemiology of CDI infection, as evidenced by an uptick in incidence and severity that is disproportionately more common in older patients. CDI, which was once thought to be a nosocomial infection linked to antibiotic exposure, has now affected previously low-risk populations in the community. New risk factors and disease recurrence pose ongoing management challenges for CDI.

However, in some areas of the US, the overall incidence of CDI has risen to the point where it has surpassed rates of methicillin-resistant S. aureus infections. The most frequently recognized cause of nosocomial diarrhea, Clostridium difficile, has been linked to epidemics of diarrhea in hospitals and long-term care facilities. The persistence of CDI suggests that it has surpassed other pathogens in the transmission of infections related to healthcare. In a recent report on threats from antibiotic resistance in the US, the Centers for Disease Control and Prevention designated CDI as an urgent threat, highlighting the need for quick and decisive action to stop this infection. Such factors are expected to drive the growth of the global market during the forecast period.

Significant Trends

The development of new vaccines is the primary trend in the global market. The increasing incidence of clostridium has encouraged companies to develop vaccines that prevent clostridium-related diseases. Vaccines provide long-term protection against clostridium. Several vaccines for clostridium are in different phases of development. Vaccines are designed to prevent clostridium and are cost-effective. They can also be used to prevent the recurrence of CDI.

companies in the market adopt strategies such as new product launches to tackle the competition in the market. Moreover, intense competition in the market is expected to compel established companies to increase their market presence. With the increasing demand for clostridium-related vaccines from end-users, companies are launching new vaccines. Thus, such activities are expected to drive the growth of the market during the forecast period.

Major Challenge

The scarcity of resources and lack of awareness in developing countries is a major challenge to the growth of the global market. The scarcity of resources such as healthcare infrastructure and lack of awareness regarding CDI in developing countries is expected to be the most significant factor impeding market growth during the forecast period. Researchers looking at the burden of CDI in resource-limited settings have noted that clinicians in developing and underdeveloped regions are much less likely to consider CDI as a diagnosis in patients presenting with community or hospital-acquired diarrhea. This is in contrast to resource-rich settings such as North America and Europe, where clinicians usually order testing for CDI (even in patients with very mild diarrhea).

Moreover, according to a recent medical survey, physicians in Asia have poor knowledge of CDI and underestimate its contribution to antibiotic-associated disease and recurrence rates. In addition, comprehensive culture and toxin testing for C. difficile infection is still limited in many Asian hospitals due to a lack of resources such as healthcare infrastructure. This can become a major challenge for the growth of the global market during the forecast period.

Key Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Who are the Major Clostridium Diagnostics Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

AstraZeneca Plc: The company offers clostridium diagnostic solutions where monoclonal antibody therapies are used to treat or prevent an increasingly broad range of diseases, including various cancers, and auto-immune and metabolic diseases. Some examples include Crohn's disease, asthma, rheumatoid arthritis, and bladder cancer.

The clostridium diagnostics market report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

  • Beckman Coulter Inc.
  • Becton Dickinson and Co.
  • bioMerieux SA
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Ferring BV
  • Fujirebio Holdings Inc.
  • Hologic Inc.
  • Huvepharma
  • Meridian Bioscience Inc.
  • Novartis AG
  • Olympus Corp.
  • Pfizer Inc.
  • QIAGEN NV
  • Siemens AG

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segments in the Market?

The market share growth by the immunoassays segment will be significant during the forecast period. Immunoassays are biochemical tests that use antibody-antigen interactions to determine the presence or concentration of a particular chemical, such as a toxin or hormone, in a solution. The practice of immunoassays will continue to increase during the forecast period due to technological advancements, cost-effectiveness, and the rapid analysis of immunoassays. Such factors will drive the growth of the immunoassays segment in the global market during the forecast period. 

Get a glance at the market contribution of various segments Request Clostridium Diagnostics Market Research Report Sample PDF

The immunoassays segment was valued at USD 1,016.40 million in 2017 and continue to grow by 2021. The immunoassays segment in the global market contributed to the maximum market share during 2022, owing to the rising incidences of chronic diseases and the extensive use of immunoassays in oncology. The most frequently used tests for detecting C. difficile toxins (TcdA and TcdB) are enzyme immunoassays (EIAs). They are simple to use, give quick, affordable results, and have good specificity. A growing number of patients with positive molecular tests for CDI lack the toxins that have historically defined disease, making it difficult to determine whether they require treatment. The demand for immunoassays is being driven by the need for better results and accurate diagnostics, which will increase the market growth during the forecast period.

Which are the Key Regions for the Market?

For more insights on the market share of various regions Request Clostridium Diagnostics Market Research Report Sample PDF !

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The US was the largest revenue contributor of revenue in the global market in the region in 2022. This was due to the common use of antibiotics in the country.  The increase in the prevalence of clostridium-related diseases in the region will drive the growth of the market during the forecast period. For instance, every year, in a hospital or care setting, about 200,000 people in the US contract CDI. CDI infections can also occur in people who are not in healthcare facilities or hospitals. Some strains of the bacterium found in the general population are more likely to affect children or cause serious infections. About 170,000 infections outside of healthcare settings occur in the US each year, and this number is rising. As CDI is commonly prevalent among the ageing population, the growth of the ageing population in the region will drive the growth of the global clostridium market in North America during the forecast period. 

Market Analyst Overview

The market is experiencing robust growth owing to the increasing prevalence of Clostridium difficile infection (CDI). This bacterium causes gut disorders such as colon inflammation, leading to symptoms like nausea, dehydration, fever, and severe abdominal pain. Antibiotic use contributes to the rise in hospital-acquired cases, prompting demand for rapid, high-sensitivity diagnostics like the Clarity C. difftoxin A/B assay by Singulex, Inc. These PCR-based tests aim to reduce false positives and false negatives, crucial for effective infection management. The market's growth is fueled by regulatory approvals and the low awareness among hospital staff, doctors, and paramedics regarding CDI's symptoms and effects. As awareness increases, the market is expected to expand further, catering to global healthcare needs.

Segment Overview

The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Technology Outlook (USD Million, 2017 - 2027)
    • Immunoassays
    • Molecular diagnostics
  • Product Outlook (USD Million, 2017 - 2027)
    • Clostridium difficile
    • Clostridium perfringens
    • Clostridium botulinum
    • Clostridium tetani
    • Clostridium sordellii
  • End-User Outlook (USD Million, 2017 - 2027)
    • Hospitals
    • Independent laboratories
    • Physicians clinics
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Australia
      • Argentina
      • Rest of the world

Clostridium Diagnostics Market Scope

Report Coverage

Details

Page number

190

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 13.69%

Market growth 2023-2027

USD 2,148.4 million

Market structure

Fragmented

YoY growth 2022-2023(%)

12.67

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 38%

Key countries

US, Canada, Germany, UK, and China

Competitive landscape

 Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks

Key companies profiled

AstraZeneca Plc, Beckman Coulter Inc., Becton Dickinson and Co., bioMerieux SA, DiaSorin SpA, F. Hoffmann La Roche Ltd., Ferring BV, Fujirebio Holdings Inc., Hologic Inc., Huvepharma, Meridian Bioscience Inc., Novartis AG, Olympus Corp., Pfizer Inc., QIAGEN NV, Siemens AG, Summit Therapeutics Inc., TECHLAB Inc., Thermo Fisher Scientific Inc., and Trinity Biotech Plc

Market dynamics

Parent market analysis, Market forecasting, market growth and trends, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

 Request  Market Research Report Sample PDF

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
  • Precise estimation of the size of the market size and its contribution to the parent market
  • Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
  • Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
  • Thorough market growth analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive market analysis and report on the factors that will challenge the market research and growth of market vendors

We can help! Our analysts can customize this market research report to meet your requirements.Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 08: Executive Summary – Chart on Incremental Growth
    • Exhibit 09: Executive Summary – Data Table on Incremental Growth
    • Exhibit 10: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 11: Parent market
    • Exhibit 12: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 13: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 14: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 15: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global clostridium diagnostics market 2017 - 2021
      • Exhibit 19: Historic Market Size – Data Table on Global clostridium diagnostics market 2017 - 2021 ($ million)
    • 4.2 Technology Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Technology Segment 2017 - 2021 ($ million)
    • 4.3 Product Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.4 End user Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – End user Segment 2017 - 2021 ($ million)
    • 4.5 Geography Segment Analysis 2017 - 2021
      • Exhibit 23: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.6 Country Segment Analysis 2017 - 2021
      • Exhibit 24: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 25: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 26: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 27: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 28: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 29: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 30: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 31: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Technology

    • 6.1 Market segments
      • Exhibit 32: Chart on Technology - Market share 2022-2027 (%)
      • Exhibit 33: Data Table on Technology - Market share 2022-2027 (%)
    • 6.2 Comparison by Technology
      • Exhibit 34: Chart on Comparison by Technology
      • Exhibit 35: Data Table on Comparison by Technology
    • 6.3 Immunoassays - Market size and forecast 2022-2027
      • Exhibit 36: Chart on Immunoassays - Market size and forecast 2022-2027 ($ million)
      • Exhibit 37: Data Table on Immunoassays - Market size and forecast 2022-2027 ($ million)
      • Exhibit 38: Chart on Immunoassays - Year-over-year growth 2022-2027 (%)
      • Exhibit 39: Data Table on Immunoassays - Year-over-year growth 2022-2027 (%)
    • 6.4 Molecular diagnostics - Market size and forecast 2022-2027
      • Exhibit 40: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 41: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 42: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
      • Exhibit 43: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Technology
      • Exhibit 44: Market opportunity by Technology ($ million)
      • Exhibit 45: Data Table on Market opportunity by Technology ($ million)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 46: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 47: Data Table on Product - Market share 2022-2027 (%)
    • 7.2 Comparison by Product
      • Exhibit 48: Chart on Comparison by Product
      • Exhibit 49: Data Table on Comparison by Product
    • 7.3 Clostridium difficile - Market size and forecast 2022-2027
      • Exhibit 50: Chart on Clostridium difficile - Market size and forecast 2022-2027 ($ million)
      • Exhibit 51: Data Table on Clostridium difficile - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Chart on Clostridium difficile - Year-over-year growth 2022-2027 (%)
      • Exhibit 53: Data Table on Clostridium difficile - Year-over-year growth 2022-2027 (%)
    • 7.4 Clostridium perfringens - Market size and forecast 2022-2027
      • Exhibit 54: Chart on Clostridium perfringens - Market size and forecast 2022-2027 ($ million)
      • Exhibit 55: Data Table on Clostridium perfringens - Market size and forecast 2022-2027 ($ million)
      • Exhibit 56: Chart on Clostridium perfringens - Year-over-year growth 2022-2027 (%)
      • Exhibit 57: Data Table on Clostridium perfringens - Year-over-year growth 2022-2027 (%)
    • 7.5 Clostridium botulinum - Market size and forecast 2022-2027
      • Exhibit 58: Chart on Clostridium botulinum - Market size and forecast 2022-2027 ($ million)
      • Exhibit 59: Data Table on Clostridium botulinum - Market size and forecast 2022-2027 ($ million)
      • Exhibit 60: Chart on Clostridium botulinum - Year-over-year growth 2022-2027 (%)
      • Exhibit 61: Data Table on Clostridium botulinum - Year-over-year growth 2022-2027 (%)
    • 7.6 Clostridium tetani - Market size and forecast 2022-2027
      • Exhibit 62: Chart on Clostridium tetani - Market size and forecast 2022-2027 ($ million)
      • Exhibit 63: Data Table on Clostridium tetani - Market size and forecast 2022-2027 ($ million)
      • Exhibit 64: Chart on Clostridium tetani - Year-over-year growth 2022-2027 (%)
      • Exhibit 65: Data Table on Clostridium tetani - Year-over-year growth 2022-2027 (%)
    • 7.7 Clostridium sordellii - Market size and forecast 2022-2027
      • Exhibit 66: Chart on Clostridium sordellii - Market size and forecast 2022-2027 ($ million)
      • Exhibit 67: Data Table on Clostridium sordellii - Market size and forecast 2022-2027 ($ million)
      • Exhibit 68: Chart on Clostridium sordellii - Year-over-year growth 2022-2027 (%)
      • Exhibit 69: Data Table on Clostridium sordellii - Year-over-year growth 2022-2027 (%)
    • 7.8 Market opportunity by Product
      • Exhibit 70: Market opportunity by Product ($ million)
      • Exhibit 71: Data Table on Market opportunity by Product ($ million)

    8 Market Segmentation by End-user

    • 8.1 Market segments
      • Exhibit 72: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 73: Data Table on End-user - Market share 2022-2027 (%)
    • 8.2 Comparison by End-user
      • Exhibit 74: Chart on Comparison by End-user
      • Exhibit 75: Data Table on Comparison by End-user
    • 8.3 Hospitals - Market size and forecast 2022-2027
      • Exhibit 76: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
      • Exhibit 79: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
    • 8.4 Independent laboratories - Market size and forecast 2022-2027
      • Exhibit 80: Chart on Independent laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Data Table on Independent laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Chart on Independent laboratories - Year-over-year growth 2022-2027 (%)
      • Exhibit 83: Data Table on Independent laboratories - Year-over-year growth 2022-2027 (%)
    • 8.5 Physicians clinics - Market size and forecast 2022-2027
      • Exhibit 84: Chart on Physicians clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Data Table on Physicians clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Chart on Physicians clinics - Year-over-year growth 2022-2027 (%)
      • Exhibit 87: Data Table on Physicians clinics - Year-over-year growth 2022-2027 (%)
    • 8.6 Market opportunity by End-user
      • Exhibit 88: Market opportunity by End-user ($ million)
      • Exhibit 89: Data Table on Market opportunity by End-user ($ million)

    9 Customer Landscape

    • 9.1 Customer landscape overview
      • Exhibit 90: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    10 Geographic Landscape

    • 10.1 Geographic segmentation
      • Exhibit 91: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 92: Data Table on Market share by geography 2022-2027 (%)
    • 10.2 Geographic comparison
      • Exhibit 93: Chart on Geographic comparison
      • Exhibit 94: Data Table on Geographic comparison
    • 10.3 North America - Market size and forecast 2022-2027
      • Exhibit 95: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 10.4 Europe - Market size and forecast 2022-2027
      • Exhibit 99: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 10.5 Asia - Market size and forecast 2022-2027
      • Exhibit 103: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 10.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 107: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 108: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 109: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 110: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 10.7 US - Market size and forecast 2022-2027
      • Exhibit 111: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 112: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 113: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 114: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 10.8 Germany - Market size and forecast 2022-2027
      • Exhibit 115: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 116: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 117: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 118: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 10.9 UK - Market size and forecast 2022-2027
      • Exhibit 119: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 120: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 121: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 122: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 10.10 China - Market size and forecast 2022-2027
      • Exhibit 123: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 124: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 125: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 126: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 10.11 Canada - Market size and forecast 2022-2027
      • Exhibit 127: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 128: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 129: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 130: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 10.12 Market opportunity by geography
      • Exhibit 131: Market opportunity by geography ($ million)
      • Exhibit 132: Data Tables on Market opportunity by geography ($ million)

    11 Drivers, Challenges, and Trends

    • 11.1 Market drivers
      • 11.2 Market challenges
        • 11.3 Impact of drivers and challenges
          • Exhibit 133: Impact of drivers and challenges in 2022 and 2027
        • 11.4 Market trends

          12 Vendor Landscape

          • 12.1 Overview
            • 12.2 Vendor landscape
              • Exhibit 134: Overview on Criticality of inputs and Factors of differentiation
            • 12.3 Landscape disruption
              • Exhibit 135: Overview on factors of disruption
            • 12.4 Industry risks
              • Exhibit 136: Impact of key risks on business

            13 Vendor Analysis

            • 13.1 Vendors covered
              • Exhibit 137: Vendors covered
            • 13.2 Market positioning of vendors
              • Exhibit 138: Matrix on vendor position and classification
            • 13.3 AstraZeneca Plc
              • Exhibit 139: AstraZeneca Plc - Overview
              • Exhibit 140: AstraZeneca Plc - Product / Service
              • Exhibit 141: AstraZeneca Plc - Key news
              • Exhibit 142: AstraZeneca Plc - Key offerings
            • 13.4 Becton Dickinson and Co.
              • Exhibit 143: Becton Dickinson and Co. - Overview
              • Exhibit 144: Becton Dickinson and Co. - Business segments
              • Exhibit 145: Becton Dickinson and Co. - Key news
              • Exhibit 146: Becton Dickinson and Co. - Key offerings
              • Exhibit 147: Becton Dickinson and Co. - Segment focus
            • 13.5 bioMerieux SA
              • Exhibit 148: bioMerieux SA - Overview
              • Exhibit 149: bioMerieux SA - Product / Service
              • Exhibit 150: bioMerieux SA - Key offerings
            • 13.6 DiaSorin SpA
              • Exhibit 151: DiaSorin SpA - Overview
              • Exhibit 152: DiaSorin SpA - Business segments
              • Exhibit 153: DiaSorin SpA - Key news
              • Exhibit 154: DiaSorin SpA - Key offerings
              • Exhibit 155: DiaSorin SpA - Segment focus
            • 13.7 F. Hoffmann La Roche Ltd.
              • Exhibit 156: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 157: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 158: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 159: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 160: F. Hoffmann La Roche Ltd. - Segment focus
            • 13.8 Ferring BV
              • Exhibit 161: Ferring BV - Overview
              • Exhibit 162: Ferring BV - Product / Service
              • Exhibit 163: Ferring BV - Key offerings
            • 13.9 Fujirebio Holdings Inc.
              • Exhibit 164: Fujirebio Holdings Inc. - Overview
              • Exhibit 165: Fujirebio Holdings Inc. - Product / Service
              • Exhibit 166: Fujirebio Holdings Inc. - Key offerings
            • 13.10 Hologic Inc.
              • Exhibit 167: Hologic Inc. - Overview
              • Exhibit 168: Hologic Inc. - Business segments
              • Exhibit 169: Hologic Inc. - Key news
              • Exhibit 170: Hologic Inc. - Key offerings
              • Exhibit 171: Hologic Inc. - Segment focus
            • 13.11 Huvepharma
              • Exhibit 172: Huvepharma - Overview
              • Exhibit 173: Huvepharma - Product / Service
              • Exhibit 174: Huvepharma - Key offerings
            • 13.12 Novartis AG
              • Exhibit 175: Novartis AG - Overview
              • Exhibit 176: Novartis AG - Business segments
              • Exhibit 177: Novartis AG - Key offerings
              • Exhibit 178: Novartis AG - Segment focus
            • 13.13 Olympus Corp.
              • Exhibit 179: Olympus Corp. - Overview
              • Exhibit 180: Olympus Corp. - Business segments
              • Exhibit 181: Olympus Corp. - Key news
              • Exhibit 182: Olympus Corp. - Key offerings
              • Exhibit 183: Olympus Corp. - Segment focus
            • 13.14 Pfizer Inc.
              • Exhibit 184: Pfizer Inc. - Overview
              • Exhibit 185: Pfizer Inc. - Product / Service
              • Exhibit 186: Pfizer Inc. - Key news
              • Exhibit 187: Pfizer Inc. - Key offerings
            • 13.15 QIAGEN NV
              • Exhibit 188: QIAGEN NV - Overview
              • Exhibit 189: QIAGEN NV - Product / Service
              • Exhibit 190: QIAGEN NV - Key news
              • Exhibit 191: QIAGEN NV - Key offerings
            • 13.16 Siemens AG
              • Exhibit 192: Siemens AG - Overview
              • Exhibit 193: Siemens AG - Business segments
              • Exhibit 194: Siemens AG - Key news
              • Exhibit 195: Siemens AG - Key offerings
              • Exhibit 196: Siemens AG - Segment focus
            • 13.17 Thermo Fisher Scientific Inc.
              • Exhibit 197: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 198: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 199: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 200: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 201: Thermo Fisher Scientific Inc. - Segment focus

            14 Appendix

            • 14.1 Scope of the report
              • 14.2 Inclusions and exclusions checklist
                • Exhibit 202: Inclusions checklist
                • Exhibit 203: Exclusions checklist
              • 14.3 Currency conversion rates for US$
                • Exhibit 204: Currency conversion rates for US$
              • 14.4 Research methodology
                • Exhibit 205: Research methodology
                • Exhibit 206: Validation techniques employed for market sizing
                • Exhibit 207: Information sources
              • 14.5 List of abbreviations
                • Exhibit 208: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              clostridium diagnostics market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis